Atara biotherapeutics to participate at the 6th annual evercore isi healthconx conference

Thousand oaks, calif.--(business wire)---- $atra #cart--atara biotherapeutics, inc. (nasdaq: atra), a leader in t-cell immunotherapy, leveraging its novel allogeneic epstein-barr virus (ebv) t-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that pascal touchon, president and chief executive officer, will participate in a fireside chat at the 6th annual evercore isi healthconx conference on tuesday, november 28, 2023, at 10:50 a.m. est. a live.
ATRA Ratings Summary
ATRA Quant Ranking